Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bone cement assessed in screw trial:

This article was originally published in Clinica

Executive Summary

Orthopaedics biomaterials company Orthovita is to begin a Norwegian clinical trial of its bone bonding cement for augmenting screws used in fracture-repairing plate constructs where the screws have failed to hold due to poor bone quality. Orthocomp, which will be assessed in the treatment of long-bone fractures, sets within minutes and becomes immediately load-bearing. The non-resorbable cement could act as an internal nut to the screw and allow the screw to stabilise the fracture, said the Malvern, Pennsylvania-based company.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT078128

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel